Effect of syncytiotrophoblast microvillous membrane treatment on gene expression in human umbilical vein endothelial cells. by Hoegh, A, Tannetta, D, Sargent, I, Borup, R, Nielsen, F, Redman, C, Sørensen, S, Hviid, T

Disruption of a novel regulatory element in the erythroid-specific promoter of the human PKLR gene causes severe pyruvate kinase deficiency. by van Wijk, R, van Solinge, W, Nerlov, C, Beutler, E, Gelbart, T, Rijksen, G, Nielsen, F

NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements. by Weischenfeldt, J, Damgaard, I, Bryder, D, Theilgaard-Mönch, K, Thoren, L, Nielsen, F, Jacobsen, SE, Nerlov, C, Porse, B

A gold-nanoparticle stoppered [2]rotaxane by Ulfkjær, A, Nielsen, F, Al-Kerdi, H, Ruβ, T, Nielsen, Z, Ulstrup, J, Sun, L, Moth-Poulsen, K, Zhang, J, Pittelkow, M

The personality trait openness is related to cerebral 5-HTT levels. by Kalbitzer, J, Frokjaer, V, Erritzoe, D, Svarer, C, Cumming, P, Nielsen, F, Hashemi, S, Baaré, W, Madsen, J, Hasselbalch, S, Kringelbach, M, Mortensen, E, Knudsen, G

Compensation for dystrophin-deficiency: ADAM12 overexpression in skeletal muscle results in increased alpha 7 integrin, utrophin and associated glycoproteins. by Moghadaszadeh, B, Albrechtsen, R, Guo, LT, Zaik, M, Kawaguchi, N, Borup, R, Kronqvist, P, Schroder, H, Davies, K, Voit, T, Nielsen, F, Engvall, E, Wewer, U

Nomenclature for factors of the HLA-system 1977. by Albert, E, Amos, D, Bodmer, W, Ceppellini, R, Dausset, J, Kissmeyer-Nielsen, F, Mayr, W, Payne, R, van Rood, J, Terasaki, P, Trnka, Z, Walford, R

Nomenclature for factors of the HLA system-1977. by Albert, E, Amos, D, Bodmer, W, Ceppellini, R, Dausset, J, Kissmeyer-Nielsen, F, Mayr, W, Payne, R, van Rood, J, Terasaki, P, Trnka, Z, Walford, R

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis by Gregory, A, Kaur, G, Punwani, D, Felce, J, Davis, S, Fugger, L, Dendrou, C, Attfield, K, Haghikia, A, Lambert, L, Leach, O, Prömel, S, Gold, R, Xifara, D, McVean, G, Butter, F, Mann, M, Poschmann, G, Nielsen, F, Siegel, R, Bell, J

TNF receptor 1 genetic risk mirrors outcome of anti-TNF therapy in multiple sclerosis. by Gregory, A, Dendrou, C, Attfield, K, Haghikia, A, Xifara, D, Butter, F, Poschmann, G, Kaur, G, Lambert, L, Leach, O, Prömel, S, Punwani, D, Felce, J, Davis, S, Gold, R, Nielsen, F, Siegel, R, Mann, M, Bell, J, McVean, G, Fugger, L